Evidence map›Paper›PMID 34939763›Full record

ArticleCell journal2021

The Protective Effect of Sulforaphane against Oxidative Stress through Activation of NRF2/ARE Pathway in Human Granulosa Cells.

Sahar Esfandyari, Ashraf Aleyasin, Zahra Noroozi, Maryam Taheri, Mahshad Khodarahmian, Mojtaba Eslami, Zahra Rashidi, Fardin Amidi

Open access · greenAbstract read
In one paragraph

Article in Cell journal, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
2.4field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Glucosinolate Derivatives: Emerging Anti-Inflammatory Agents.Pharmaceuticals (Basel, Switzerland) · 2026
    Review
  6. Antioxidants (Basel, Switzerland) · 2025
    Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Targeting Nrf2 signaling in dry eye.International journal of ophthalmology · 2024
    Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Sahar EsfandyariDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Ashraf AleyasinDepartment of Infertility, Shariati Hospital, Tehran University of Medical Sciences, Tehran, Iran.
Zahra NorooziDepartment of Molecular Medicine, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Maryam TaheriIslamic Azad University, Science and Research Branch, Tehran, Iran.
Mahshad KhodarahmianDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Mojtaba EslamiDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.
Zahra RashidiFertility and Infertility Research Center, Health Technology Institute, Kermanshah University of Medical Sciences, Kermanshah, Iran.
Fardin AmidiDepartment of Anatomy, School of Medicine, Tehran University of Medical Sciences, Tehran, Iran.Email: famidi@sina.tums.ac.ir.
Tehran University of Medical Sciences · IRShariati Hospital · IRIslamic Azad University, Science and Research Branch · IRKermanshah University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveSulforaphane (SFN) is a natural free radical scavenger that can reduce oxidative stress (OS) through mediating nuclear factor (erythroid-derived 2)-like 2 (NF-E2-related factor 2 or NRF2)/antioxidant response element (ARE) signaling pathway and the downstream antioxidant enzymes. Here, we intended to study the role of SFN in OSinduced human granulosa cells (GCs) by investigating the intracellular levels of reactive oxygen species (ROS), cell death, and NRF2-ARE pathway. MATERIALS AND

methodsThis experimental study was conducted on GCs of 12 healthy women who had normal menstrual cycles with no history of polycystic ovary syndrome (PCOS), endometriosis, menstrual disorders, hyperprolactinemia, or hormonal therapy. After isolation of GCs, the MTT assay was performed to explore GCs viability after treatment with SFN in the presence or absence of H

resultsPretreatment of GCs with SFN attenuated intracellular ROS production and apoptosis rate in the H

conclusionOur study demonstrated that SFN protects human GCs against H

Indexed as

Granulosa CellsNF-E2-Related Factor 2Oxidative StressSulforaphane

Identifiers

PMID34939763
PMCPMC8665974
OpenAlexW4200498561

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.